Wearable ultrasound device reduces amyloid, boosts cognition in Alzheimer’s mouse models. Neuroticism linked to insomnia in epilepsy, with anxiety and depression mediating the effect. AI model analyzes brain scans to detect Alzheimer’s stage with 99% accuracy—potentially enabling faster, earlier ... Older adults with insomnia face a 3x higher depression risk when exposed to inflammation, study finds. Behavioral therapy matches drug treatment in easing overactive bladder symptoms in Parkinson’s without added side effects. Genetic evidence links GERD, depression, and obesity to increased COPD risk, highlighting key comorbidity targets. Ambroxol was safe in Parkinson disease dementia but showed no cognitive benefit, study finds. Stopping antidepressants causes mild, short-term symptoms like dizziness but no early increase in depression. Ambroxol was safe in Parkinson’s dementia but showed no clear cognitive benefit. Sleep tourism is booming—but real sleep health needs more than a vacation, says Dr. Anne Marie Morse. Nutritional epigenetics may help prevent autism and ADHD via maternal diet changes. Excess brain iron in Down syndrome linked to oxidative damage and early-onset Alzheimer’s, new study finds. Psychedelics may ease depression and PTSD by reducing brain inflammation and restoring vascular and immune balance. A parent-focused therapy improved asthma control and ADHD symptoms in kids—while helping caregivers cope. AI is transforming sleep medicine, boosting access, streamlining care, and empowering clinicians—not replacing them. A father's mental health may have a more immediate impact on childhood development than previously believed. Wearable sleep tech offers insights—but are we chasing data over real rest? Dr. Anne Marie Morse weighs in. α-synuclein PET tracers may transform Parkinson’s diagnosis, tracking, and trials, says Merck’s Robert Drolet, PhD. Children who received a greater degree of maternal warmth at 3 years had greater perceived social safety at adolescence. Epilepsy and seizure drug use were significantly more common in patients with FTD vs those with Alzheimer’s.